Simris Group
0,126 SEK +6,33%Vær den første som følger denne virksomhed
Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.
Læs mereOmsætning
4,35 mio.
EBIT %
-842,3 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
SIMRIS B
Daglig lav / høj pris
0,115 / 0,126
SEK
Markedsværdi
43,86 mio. SEK
Aktieomsætning
38,6 t SEK
Volumen
315 t
Finanskalender
Delårsrapport
15.05.2024
Generalforsamling
29.05.2024
Delårsrapport
14.08.2024
Delårsrapport
13.11.2024
Årsrapport
26.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Avanza Pension | 7,1 % | 7,1 % |
SIX SIS AG, W8IMY | 5,3 % | 5,3 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2023
SIMRIS GROUP CONFIRMS A TERM EXTENSION TO FLEXIBLE FUNDING FACILITY
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools